Kura Oncology: A Contender In The Field Of Precision Medicine [Seeking Alpha]
KIRIN HLDGS CO LTD S/ADR (KNBWY)
US:NASDAQ Investor Relations:
kirinholdings.co.jp/english/ir
Company Research
Source: Seeking Alpha
Ziftomenib, Kura's most advanced drug candidate, targets AML with NPM1 mutations, showing promising Phase 1b and a potentially unlocking a $3 billion market in the U.S. Kura's pipeline also includes tipifarnib and KO-2806, but the market remains skeptical of their near-term value, justifying a HOLD rating. Investors should watch for progress in ziftomenib's crucial registration enabling Phase 2 study, or new catalysts from tipifarnib and KO-2806. KURA stock presents deep value at the current price, although the collaboration with Kyowa Kirin will require investors to think long-term, and the catalyst for higher prices is not yet clear. Precision oncology has a storied history, boasting some of the most innovative and lucrative drugs. This branch uses cutting-edge diagnostics to tailor a therapy through analysis of the Recommended For You About KURA Stock More on KURA Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
KNBWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNBWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNBWY alerts
High impacting KIRIN HLDGS CO LTD S/ADR news events
Weekly update
A roundup of the hottest topics
KNBWY
News
- New Report Reveals Wisconsin Dairy Industry Up 16%, Contributing $52.8 Billion to State's Economy [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical CompanyBusiness Wire
- Kyowa Hakko USA Receives U.S. Patent for Cognizin® Citicoline, Cementing Its Position as the Gold Standard Ingredient for Cognitive HealthPR Web
- Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024Business Wire